← back to search

Angela Williams‐Diaz

Merck & Co., Inc., Rahway, NJ, USA (United States) · US
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Respiratory viral infections research, and Antifungal resistance and susceptibility.
h-index
11
citations
3,160
works
14
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19
Annals of Internal Medicine 2022cited by 71position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Norio Ohmagari · National Center for Global Health and Medicine1 papers (2022–2022)Amanda Paschke · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2022–2022)Hong Wan · King University1 papers (2022–2022)Michelle Brown · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2022–2022)Matthew G. Johnson · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2022–2022)Ying Zhang · North Sichuan Medical University1 papers (2022–2022)Timo Wolf · Goethe University Frankfurt1 papers (2022–2022)Sanjay Bhagani · Royal Free London NHS Foundation Trust1 papers (2022–2022)Pablo Andrés Moncada · Fundación Valle del Lili1 papers (2022–2022)Elizabeth R. Duke · Fred Hutch Cancer Center1 papers (2022–2022)Jade Ghosn · Délégation Paris 51 papers (2022–2022)Lesley Burgess · Clinical Trial Investigators1 papers (2022–2022)Matteo Bassetti · Istituto Nazionale di Fisica Nucleare, Sezione di Genova1 papers (2022–2022)Carisa De Anda · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2022–2022)Amy Puenpatom · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2022–2022)